Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
Date:10/30/2008

or the licensing of the nasal dosage form of bepotastine. The increase in research and development expenses for the third quarter of 2008, excluding the prior year quarter's milestone expenses of $3.0 million, was primarily the result of an increase in clinical development costs, which include clinical investigator fees, study monitoring costs and data management costs, due to the work performed on our key product candidates: Xibrom 0.09% once daily, Bepreve Phase III efficacy, Bepreve safety and T-Pred studies. Research and development expenses during the third quarter of 2008 included $0.2 million in stock-based compensation expense.

Selling, general, and administrative expenses for the third quarter ended September 30, 2008 were $13.2 million, as compared to $11.0 million for the same period in 2007. The $2.2 million increase in selling, general and administrative expenses in 2008 as compared to 2007 primarily results from higher sales and marketing expenses associated with the expansion of our sales force, which occurred in the first quarter of 2008 ($0.6 million), an overall increase in administrative costs, primarily related to legal expenses ($1.3 million) and an increase in our stock-based compensation expense ($0.3 million). Selling, general, and administrative expenses during the third quarter of 2008 include $0.8 million in stock-based compensation expense.

Interest expense for the third quarter ended September 30, 2008 was $2.4 million, as compared to $1.2 million for the same period in 2007. The increase of $1.2 million is primarily attributable to the write off of the unamortized deferred financing costs, the unamortized debt discount and the value of the embedded derivative associated with the senior subordinated convertible notes, which were paid in full as of the quarter ended September 30, 2008.

The net loss for the third quarter of 2008 was $7.4 million, or $0.22 per share, compared with a net loss of $8.2 million, or $0.25 pe
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
2. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
3. PUR Water Filtration Systems Can Remove Pharmaceuticals Identified in U.S. Tap Water - More Than 99 Percent for PUR Faucet Filters and More Than 96 Percent for PUR Pitchers*
4. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
5. Watson Pharmaceuticals Reports Third Quarter 2008 Results
6. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
7. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R)
10. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
11. CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Angeles, CA (PRWEB) July 30, 2014 ... the Chao Pinhole Surgical Technique®, the revolutionary minimally invasive ... Dennis Shanelec, considered by many of his peers to ... special guest speaker at a recent Chao Pinhole Surgical ... Alhambra, CA. Dr. Shanelec is the recipient of the ...
(Date:7/30/2014)... DC (PRWEB) July 30, 2014 ... appreciation to U.S. Sens. Thad Cochran (R-MS) and ... for improvements in telemedicine coverage under Medicare, Medicaid ... and Wicker, both Mississippi Republicans, introduced the Telehealth ... to a House version, H.R. 3306, introduced by ...
(Date:7/30/2014)... 2014 The Institute for Integrative Nutrition ... announce that Arianna Huffington has joined as a guest speaker ... Health Coach Training Program . , Arianna Huffington is the ... news and blogging site that won a Pulitzer Prize in ... books and was included on the Forbes “Most Powerful Women” ...
(Date:7/30/2014)... 2014 Frozen shoulder (Adhesive capsulitis) affects 10-20 ... develop this nasty condition which occurs most frequently in people ... up to two and half years if not treated. , ... with good reason: it can render your shoulder so stiff, ... if you aren't in too much pain to get dressed ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 (HealthDay ... the agitation that commonly strikes people with dementia, a new ... found evidence that watering plants, or sitting or strolling in ... The study authors cautioned that the effects of gardens on ... the evidence of a benefit is limited. But experts said ...
Breaking Medicine News(10 mins):Health News:Periodontist Dr. Dennis Shanelec Comments On The Chao Pinhole Surgical Technique® Training Course 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... Denver, Colorado (June 1, 2011) Five advocacy organizations ... granted travel awards by the International Association for the ... the 14th World Conference on Lung Cancer, July 3-7 ... Australian Lung Foundation (Australia): The Australian Lung Foundation is ...
... (HealthDay News) -- Age alone should not be the sole determining ... a new study suggests. In following 216 women over the ... if screened properly, people who have facelifts after age 65 are ... , , More than 12 percent of the U.S. ...
... , WEDNESDAY, June 1 (HealthDay News) -- Boys ... significantly higher risk of developing a substance abuse problem ... "Our study, which is one of the largest ... supports the association between ADHD and substance abuse ...
... American Society for Gastrointestinal Endoscopy (ASGE) and the ... updated their 2003 joint guideline for reprocessing gastrointestinal ... account evolved technology and disinfection systems. ... in collaboration with multiple physician and nursing organizations, ...
... anticancer chemotherapeutics. However, it has some severe side effects ... the kidneys. Understanding the mechanisms underlying this toxicity could ... with cisplatin to protect the kidney during chemotherapy. In ... Dong, at Georgia Health Sciences University, Augusta, has now ...
... Dana-Farber Cancer Institute have identified an overactive network ... cells enriched in triple-negative breast tumors, a typically ... therapies. Kornelia Polyak, MD, PhD, a breast ... a large proportion of cells within these tumors ...
Cached Medicine News:Health News:5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam 2Health News:5 advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam 3Health News:Plastic Surgery Risks May Depend on More Than Age 2Health News:Children With ADHD More Prone to Substance Abuse: Study 2Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 2Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 3Health News:ASGE and SHEA issue updated multisociety guideline on reprocessing flexible gastrointestinal endoscopes 4Health News:Scientists identify overactive genes in aggressive breast cancers 2
(Date:7/30/2014)... CLARA, Calif. , July 30, 2014 ... economy, released a study today that examines ... biopharma and medical device companies.  According to the annual ... saw the biggest potential returns since SVB started tracking ... year of the IPO.  Built on solid healthcare M&A ...
(Date:7/30/2014)... , July 30, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... commitment from a prominent international research and development ... on promoting innovative research-based initiatives, including those addressing ... spray for the delivery of naloxone that could ...
(Date:7/30/2014)... 2014   Epic Sciences, Inc. ("Epic"), ... develops novel diagnostics to personalize and advance the ... completion of a $30 million Series C Preferred ... (RMI) and Arcus Ventures, existing investors Domain Associates, ... well as undisclosed individual investors. With the proceeds ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3
... Inc. (NYSE: HSP ), a leading global specialty ... will present at the Morgan Stanley Global Healthcare Conference on ... presentation is scheduled to begin at 8:35 a.m. Eastern time ... all interested parties through a live audiocast accessible via the ...
... Wright Therapy Products, Inc. announced today that ... Executive Officer of the company.  The company, based ... devices targeted for the treatment of lymphedema, venous ... Wright Therapy after holding senior financial and sales ...
Cached Medicine Technology:Industry Leaders Hinson and Friel Join Wright Therapy Products 2
... Oxylab pO2 probes feature response ... seconds for real-time monitoring of ... Oxylab LDFTM, measurements of pO2, ... be obtained from the same ...
Spherical Burr for FR030R, 5 mm....
Tungsten Carbide Burr "HM", 0,7 mm, ISO-No. 007....
"Rosen" burr, 0,7 mm, ISO-No. 007....
Medicine Products: